A Registry-Based Perspective of Interventional Clinical Trials for Duchenne Muscular Dystrophy
Jeet H Chaudhary, Jiya O Chacko, Viswabhaskar Susarla, Sai Subramanya Kashyap Peraboina, Shrabya Sen · 2026
Read A Registry-Based Perspective of Interventional Clinical Trials for Duchenne Muscular Dystrophy by Jeet H Chaudhary, Jiya O Chacko, Viswabhaskar Susarla, Sai Subramanya Kashyap Peraboina, Shrabya Sen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13546769.txt.
Description
Jeet Chaudhary and co-authors map clinical trials for a severe muscle disease in a 2026 study. Duchenne muscular dystrophy is an inherited disorder that weakens muscles over time and shortens life. Trials are key to better care, but the overall shape of trial work in this field had not been fully described.
The team searched a public trial registry as of May 2026 and kept 232 interventional trials with a disease specific aim. Most trials enrolled males only, and most had treatment as their main purpose. Drug trials were the largest group, and phase two was the most common stage. The study also tracks funding, design, and how often results are posted. The authors aim to show where trial effort in this field is strong or thin.
Catalog record
| CREATOR | Jeet H Chaudhary, Jiya O Chacko, Viswabhaskar Susarla, Sai Subramanya Kashyap Peraboina, Shrabya Sen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |